FGL2 and type 2 diabetes nephropathy: In summary, this study reports the novel finding that fgl2 can act as an activator of renal microthrombi contributing to glomerular hypertension and renal ischemia, which can trigger histologic alterations in experimental type 2 diabetic nephropathy.